We're building a better ClinicalTrials.gov. Check it out and tell us what you think!

Key Record Dates

ClinicalTrials.gov Identifier: NCT04701060
Brief Title: Camrelizumab Combined With Apatinib for Perioperative Treatment of Resectable Primary Hepatocellular Carcinoma

First Submitted : January 4, 2021
First Submitted that Met QC Criteria : January 7, 2021
First Posted : January 8, 2021

Last Update Submitted that Met QC Criteria : November 3, 2021
Last Update Posted : November 5, 2021